MARINUS PHARMACEUTICALS INC's ticker is MRNS and the CUSIP is 56854Q101. A total of 67 filers reported holding MARINUS PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $382,000 | -5.2% | 31,330 | 0.0% | 0.02% | -9.1% |
| Q3 2020 | $403,000 | +26.7% | 31,330 | -75.0% | 0.02% | +15.8% |
| Q2 2020 | $318,000 | +25.2% | 125,321 | 0.0% | 0.02% | -9.5% |
| Q1 2020 | $254,000 | -6.3% | 125,321 | 0.0% | 0.02% | +40.0% |
| Q4 2019 | $271,000 | +40.4% | 125,321 | 0.0% | 0.02% | +15.4% |
| Q3 2019 | $193,000 | -62.9% | 125,321 | 0.0% | 0.01% | -48.0% |
| Q2 2019 | $520,000 | +9.0% | 125,321 | +9.7% | 0.02% | +25.0% |
| Q1 2019 | $477,000 | +311.2% | 114,221 | +79.8% | 0.02% | +185.7% |
| Q3 2016 | $116,000 | +43.2% | 63,517 | 0.0% | 0.01% | +16.7% |
| Q2 2016 | $81,000 | -74.5% | 63,517 | +7.6% | 0.01% | -76.0% |
| Q1 2016 | $318,000 | -29.5% | 59,017 | 0.0% | 0.02% | 0.0% |
| Q4 2015 | $451,000 | -8.3% | 59,017 | 0.0% | 0.02% | +4.2% |
| Q3 2015 | $492,000 | – | 59,017 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 3,977,453 | $15,194,000 | 8.96% |
| Granite Point Capital Management, L.P. | 2,638,321 | $10,078,000 | 0.98% |
| New Leaf Venture Partners, L.L.C. | 342,550 | $1,309,000 | 0.71% |
| 683 Capital Management, LLC | 1,200,000 | $4,584,000 | 0.40% |
| Virtus ETF Advisers LLC | 80,389 | $307,000 | 0.27% |
| Iguana Healthcare Management, LLC | 100,000 | $382,000 | 0.25% |
| THREE BAYS CAPITAL LP | 944,300 | $3,607,000 | 0.25% |
| Granite Point Capital Management, L.P. | 549,900 | $2,101,000 | 0.20% |
| Cormorant Asset Management, LP | 478,111 | $1,826,000 | 0.14% |
| GMT CAPITAL CORP | 2,533,798 | $9,680,000 | 0.12% |